Prognosticating Outcomes and Nudging Decisions With Electronic Records in the ICU Trial (PONDER-ICU)

August 3, 2022 updated by: University of Pennsylvania

Behavioral Economic Approaches to Improve Palliative Care for Critically Ill Patients

This is a pragmatic, stepped-wedge, cluster randomized trial testing the real-world effectiveness of two different electronic health record (EHR) behavioral interventions in improving a number of patient- and family-centered processes and outcomes of care among seriously ill hospitalized patients. The investigators hypothesize that outcomes can be improved without raising costs by requiring intensive care unit clinicians to (i) document a prognostic estimate and (ii) provide a justification if they choose not to offer patients the option of comfort-oriented care. To test this hypothesis the investigators will conduct a 33-month trial at 17 intensive care units in 10 hospitals using the same Cerner EHR within Atrium Health System.

Study Overview

Detailed Description

The PONDER-ICU trial aims to generate large-scale, experimental evidence regarding the real-world effectiveness of two different electronic health record (EHR) behavioral interventions in improving a number of patient- and family-centered processes and outcomes of care among seriously ill hospitalized patients. The interventions are designed to increase intensive care unit (ICU) physicians' and advanced practitioners' (physician assistants and nurse practitioners) engagement of critically ill patients and caregivers in discussions about alternative treatment options, including care focused on comfort. To achieve this goal, the investigators will conduct a 33-month pragmatic, stepped-wedge cluster randomized clinical trial at 17 ICUs within 10 Atrium Health System hospitals. The investigators hypothesize that outcomes can be improved without raising costs by requiring ICU clinicians to (i) document a prognostic estimate (Intervention A) and (ii) provide a justification if they choose not to offer patients the option of comfort-oriented care (Intervention B). Approximately 4,750 adult patients (1) with chronic life-limiting illness and receiving continuous mechanical ventilation for ≥48 hours will be enrolled. Participating hospitals will be randomized into 5 clusters of 2 hospitals each. Each hospital will first contribute a minimum of 5 months of data collection during usual care in a control phase. Then, using the step-wedge design, all hospitals will implement the two EHR-based interventions. The order in which the interventions will be adopted and the timing of adoption at each hospital will both be determined by random assignment. After 12 months of utilizing Intervention A or Intervention B, each hospital will adopt and implement the second intervention in combination with the other. By the end of the trial, all hospitals will have utilized the combined interventions for at least 4 months. The primary outcome is a composite measure of hospital length of stay and mortality. Secondary outcomes include an array of clinical outcomes, as well as palliative care-related process measures.

Study Type

Interventional

Enrollment (Actual)

3500

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • North Carolina
      • Albemarle, North Carolina, United States, 28001
        • Carolinas HealthCare System Stanly
      • Charlotte, North Carolina, United States, 28203
        • Carolinas Medical Center
      • Charlotte, North Carolina, United States, 28025
        • Carolinas HealthCare System, NorthEast
      • Charlotte, North Carolina, United States, 28207
        • Atrium Health CMC-Mercy
      • Charlotte, North Carolina, United States, 28210
        • Atrium Health Pineville
      • Charlotte, North Carolina, United States, 28262
        • Atrium Health University City
      • Lincolnton, North Carolina, United States, 28092
        • Atrium Health Lincoln
      • Monroe, North Carolina, United States, 28112
        • Atrium Health Union
      • Morganton, North Carolina, United States, 28655
        • Carolinas HealthCare System Blue Ridge-Morganton
      • Shelby, North Carolina, United States, 28150
        • Atrium Health Cleveland

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. ≥18 years old; AND
  2. Admitted to 1 of the 17 participating ICUs; AND
  3. Receipt of continuous mechanical ventilation for ≥ 48 hours (without interruption); AND
  4. ≥ 1 life-limiting illness present on admission (ICD-9/10 code or discrete medical history data from EHR in prior 12 months):

    1. Chronic obstructive pulmonary disease
    2. Cirrhosis
    3. Congestive heart failure
    4. Dementia (all types)
    5. End-stage renal disease
    6. Hematologic malignancy
    7. Metastatic malignancy
    8. Motor neuron disease
    9. Pulmonary fibrosis
    10. Solid organ malignancy

Exclusion Criteria:

1) Patients younger than 18 years old are excluded.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: HEALTH_SERVICES_RESEARCH
  • Allocation: RANDOMIZED
  • Interventional Model: CROSSOVER
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: EHR-Based Intervention A
Intervention A (Prognostication) will be an EHR-based screen prompt triggered for eligible patients. The intervention will consist of no more than two questions that can be completed in two minutes or less. Completion of the prompt will be encouraged but not required, and adherence will be assessed in a minimally intrusive manner.
Intervention A will be a prompt for clinicians to document an estimated prognosis for patients at 6 months, and an assessment of predicted functional outcome if expected to survive.
Other Names:
  • Prognostication
ACTIVE_COMPARATOR: EHR-Based Intervention B
Intervention B (Accountable Justification) will be an EHR-based screen prompt triggered for eligible patients. The intervention will consist of no more than two questions that can be completed in two minutes or less. Completion of the prompt will be encouraged but not required, and adherence will be assessed in a minimally intrusive manner.
Intervention B will entail a prompt for clinicians to provide a reason for not offering patients and their families the alternative of care focused entirely on comfort despite recommendations from critical care professional societies to do so for patients at high risk for death or severely impaired functional recovery.
Other Names:
  • Accountable Justification
ACTIVE_COMPARATOR: Combined EHR-Based Intervention (A+B)
Intervention A and B prompts will be combined and triggered for eligible patients simultaneously. Completion of the prompt will be encouraged but not required, and adherence will be assessed in a minimally intrusive manner.
Intervention A will be a prompt for clinicians to document an estimated prognosis for patients at 6 months, and an assessment of predicted functional outcome if expected to survive.
Other Names:
  • Prognostication
Intervention B will entail a prompt for clinicians to provide a reason for not offering patients and their families the alternative of care focused entirely on comfort despite recommendations from critical care professional societies to do so for patients at high risk for death or severely impaired functional recovery.
Other Names:
  • Accountable Justification
NO_INTERVENTION: Pre-Intervention (Control)
There is no trial-driven approach to care. All hospitals contribute a minimum of 5 months of outcomes data prior to adopting the intervention. Pre-specified outcomes data will be electronically extracted for patients meeting eligibility criteria but there will be no attempt to influence delivery of usual care within the hospital. The length of the control phase will differ at each hospital, dependent on the sequence in which hospitals are assigned to switch to the intervention phase.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Composite Measure: Length of Stay and In-Hospital Mortality
Time Frame: Duration of hospital stay, an expected average of 16 days
The primary outcome is a composite measure of hospital length-of-stay and mortality that ranks deaths along the length-of-stay distribution
Duration of hospital stay, an expected average of 16 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in code status
Time Frame: Duration of hospital stay, an expected average of 16 days
Change in documented code status during hospital admission
Duration of hospital stay, an expected average of 16 days
Initiation of additional forms of life-support
Time Frame: Duration of hospital stay, an expected average of 16 days
Initiation of additional form of life-support (e.g. surgical feeding tube, dialysis) during hospital admission
Duration of hospital stay, an expected average of 16 days
Palliative care consult
Time Frame: Duration of hospital stay, an expected average of 16 days
Receipt of palliative care consult during hospital admission
Duration of hospital stay, an expected average of 16 days
Time to palliative care consult
Time Frame: Duration of hospital stay, an expected average of 16 days
The number of hours from ICU admission to inpatient palliative care consult
Duration of hospital stay, an expected average of 16 days
Palliative withdrawal of mechanical ventilation
Time Frame: Duration of hospital stay, an expected average of 16 days
Palliative withdrawal of mechanical ventilation during hospital admission
Duration of hospital stay, an expected average of 16 days
Receipt of cardiopulmonary resuscitation (CPR)
Time Frame: Duration of hospital stay, an expected average of 16 days
CPR prior to death or discharge
Duration of hospital stay, an expected average of 16 days
ICU mortality
Time Frame: Duration of hospital stay, an expected average of 16 days
ICU mortality
Duration of hospital stay, an expected average of 16 days
ICU length of stay
Time Frame: Duration of hospital stay, an expected average of 16 days
ICU length of stay (hours)
Duration of hospital stay, an expected average of 16 days
ICU readmission
Time Frame: Duration of hospital stay, an expected average of 16 days
Readmission to an ICU within the same hospitalization
Duration of hospital stay, an expected average of 16 days
Duration of mechanical ventilation
Time Frame: Duration of hospital stay, an expected average of 16 days
Hours of mechanical ventilation during hospital admission
Duration of hospital stay, an expected average of 16 days
Time to withdrawal of life-support
Time Frame: Duration of hospital stay, an expected average of 16 days
The number of hours from trial enrollment to time that comfort-care order is placed
Duration of hospital stay, an expected average of 16 days
Hospital discharge disposition
Time Frame: Duration of hospital stay, an expected average of 16 days
Hospital discharge disposition to home, hospice, long-term acute care, nursing facility, or rehabilitation
Duration of hospital stay, an expected average of 16 days
Quality of Dying & Death (1-item)
Time Frame: 48-72 hours following an in-hospital death
Nurse-reported postmortem rating of a patient's dying experience
48-72 hours following an in-hospital death
30-day hospital readmission
Time Frame: 30 days
30-day hospital readmission
30 days
90-day hospital readmission
Time Frame: 30 days
30-day hospital readmission
30 days
180-day hospital readmission
Time Frame: 30 days
30-day hospital readmission
30 days
30-day mortality
Time Frame: 30 days
Mortality rate at 30 days
30 days
90-day mortality
Time Frame: 90 days
Mortality rate at 90 days
90 days
180-day mortality
Time Frame: 180 days
Mortality rate at 180 days
180 days
Hospital free days
Time Frame: 180 days
Hospital free days within 180 days
180 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Scott D Halpern, PhD, MD, University of Pennsylvania

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

February 1, 2018

Primary Completion (ACTUAL)

April 24, 2021

Study Completion (ACTUAL)

June 30, 2022

Study Registration Dates

First Submitted

April 25, 2017

First Submitted That Met QC Criteria

May 1, 2017

First Posted (ACTUAL)

May 4, 2017

Study Record Updates

Last Update Posted (ACTUAL)

August 8, 2022

Last Update Submitted That Met QC Criteria

August 3, 2022

Last Verified

August 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • UPenn IRB #826933
  • 52635 (Patrick and Catherine Weldon Donaghue Foundation)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Critical Illness

Clinical Trials on EHR-Based Intervention A

Subscribe